Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting.
Nicholas SB, Correa-Rotter R, Desai NR, Guo L, Navaneethan SD, Pantalone KM, Wanner C, Hamacher S, Fatoba ST, Horvat-Broecker A, Garreta-Rufas A, Gay A, Merz M, Wheeler DC. Nicholas SB, et al. Among authors: guo l. J Nephrol. 2024 Sep 28. doi: 10.1007/s40620-024-02070-y. Online ahead of print. J Nephrol. 2024. PMID: 39340711
Effects of liraglutide or lifestyle interventions combined with other antidiabetic drugs on abdominal fat distribution in people with obesity and type 2 diabetes mellitus evaluated by the energy spectrum ct: A prospective randomized controlled study.
Yu D, Zou M, Pan Q, Song Y, Li M, Zhang X, Zhou Y, Wang X, Guo L. Yu D, et al. Among authors: guo l. Front Endocrinol (Lausanne). 2022 Aug 26;13:951570. doi: 10.3389/fendo.2022.951570. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36093105 Free PMC article. Clinical Trial.
21,255 results
You have reached the last available page of results. Please see the User Guide for more information.